Patent ID: 8529946

Claim:
A method for manufacturing an oral antihistamine tablet consisting of: a) 5-20 weight percent of loratadine or descarboethoxyloratadine; b) 60-86 weight percent of a filler; c) 1-5 weight percent of a water soluble polymeric binder; d) 1-7 weight percent of a taste enhancing agent; e) 2.5-10 weight percent of a disintegrant; and f) sodium stearate, wherein the method consists of the following steps: i) wet granulating with water: A) the loratadine or descarboethoxyloratadine; B) 40-70 weight percent of a first allotment of the filler based upon the total weight of the filler employed in the tablet wherein the first allotment of filler consists of mannitol and microcrystalline cellulose; and C) the water soluble polymeric binder; ii) drying and screening the granules formed in step (i); iii) blending the granules from step (i) with: (A) the disintegrant; (B) 30-60 weight percent of a second allotment of filler based upon the total weight of the filler employed in the tablet wherein the filler is selected from the group consisting of lactose, mannitol and combinations of the foregoing; (C) the taste enhancing agent; and (D) sodium stearate, and iv) compressing the blend of step (iii) into a tablet with a hardness between 0.75 and 1.5 kp and wherein the tablet dissolves in an aqueous media within 5 minutes and disintegrates when placed in a buccal cavity of a patient to enable swallowing with or without water.